Ubs Group Ag Cumberland Pharmaceuticals Inc Transaction History

Ubs Group Ag

$452 Billion
Q3 2024

A detailed history of Ubs Group Ag transactions in Cumberland Pharmaceuticals Inc stock. As of the latest transaction made, Ubs Group Ag holds 9,671 shares of CPIX stock, worth $21,953. This represents 0.0% of its overall portfolio holdings.

Number of Shares

9,671

Previous 6,870 40.77%

Holding current value

$21,953

Previous $10,000 20.0%

% of portfolio

0.0%

Previous 0.0%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$1.22 - $1.53 $3,417 - $4,285	2,801 Added 40.77%	9,671 $12,000
Q2 2024 Aug 13, 2024	BUY	$1.39 - $1.78 $7,057 - $9,037	5,077 Added 283.16%	6,870 $10,000
Q1 2024 May 13, 2024	BUY	$1.68 - $2.24 $2,827 - $3,769	1,683 Added 1530.0%	1,793 $3,000
Q4 2023 Feb 09, 2024	BUY	$1.6 - $2.14 $176 - $235	110 New	110 $0
Q2 2023 Aug 11, 2023	BUY	$1.47 - $2.01 $8,514 - $11,641	5,792 Added 205.1%	8,616 $12,000
Q1 2023 May 12, 2023	SELL	$1.92 - $2.75 $1,726 - $2,472	-899 Reduced 24.15%	2,824 $5,000
Q4 2022 Feb 08, 2023	BUY	$2.11 - $2.6 $7,855 - $9,679	3,723 New	3,723 $8,000
Q2 2022 Aug 10, 2022	BUY	$1.93 - $3.03 $970 - $1,524	503 Added 15.34%	3,783 $8,000
Q1 2022 May 16, 2022	BUY	$2.56 - $4.98 $8,396 - $16,334	3,280 New	3,280 $9,000
Q4 2021 Feb 14, 2022	SELL	$2.2 - $6.94 $4,252 - $13,415	-1,933 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$2.66 - $3.45 $3,904 - $5,064	1,468 Added 315.7%	1,933 $5,000
Q2 2021 Aug 13, 2021	SELL	$2.59 - $3.3 $6,511 - $8,296	-2,514 Reduced 84.39%	465 $1,000
Q1 2021 May 12, 2021	BUY	$2.99 - $3.58 $2,634 - $3,153	881 Added 41.99%	2,979 $9,000
Q4 2020 Feb 11, 2021	SELL	$2.9 - $3.3 $298 - $339	-103 Reduced 4.68%	2,098 $6,000
Q3 2020 Nov 12, 2020	SELL	$3.14 - $3.48 $6,066 - $6,723	-1,932 Reduced 46.75%	2,201 $7,000
Q2 2020 Jul 31, 2020	BUY	$3.17 - $4.01 $4,029 - $5,096	1,271 Added 44.41%	4,133 $14,000
Q1 2020 May 01, 2020	BUY	$3.45 - $5.33 $4,540 - $7,014	1,316 Added 85.12%	2,862 $10,000
Q4 2019 Feb 14, 2020	BUY	$4.68 - $5.79 $7,235 - $8,951	1,546 New	1,546 $8,000
Q2 2019 Aug 14, 2019	SELL	$5.35 - $6.8 $5,350 - $6,800	-1,000 Closed	0 $0
Q1 2019 May 14, 2019	SELL	$5.06 - $6.5 $13,717 - $17,621	-2,711 Reduced 73.05%	1,000 $6,000
Q4 2018 Feb 14, 2019	SELL	$5.31 - $7.0 $6,451 - $8,505	-1,215 Reduced 24.67%	3,711 $22,000
Q3 2018 Nov 14, 2018	BUY	$5.5 - $6.3 $11,572 - $13,255	2,104 Added 74.56%	4,926 $28,000
Q2 2018 Aug 14, 2018	BUY	$5.91 - $6.9 $8,232 - $9,611	1,393 Added 97.48%	2,822 $17,000
Q1 2018 May 15, 2018	SELL	$6.62 - $7.12 $5,170 - $5,560	-781 Reduced 35.34%	1,429 $10,000
Q4 2017 Feb 14, 2018	BUY	$6.79 - $7.96 $943 - $1,106	139 Added 6.71%	2,210 $16,000
Q3 2017 Nov 14, 2017	SELL	$6.47 - $7.21 $6,851 - $7,635	-1,059 Reduced 33.83%	2,071 $15,000
Q2 2017 Aug 14, 2017	BUY	N/A	1,728 Added 123.25%	3,130 $22,000
Q1 2017 Nov 14, 2017	BUY	N/A	1,402	1,402 $10,000

Others Institutions Holding CPIX

# of Institutions

Shares Held

1.97M

Call Options Held

44.2K

Put Options Held

View Full List

About CUMBERLAND PHARMACEUTICALS INC

Ticker CPIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 14,661,900
Market Cap $33.3M
Description
Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products for hospital acute care, gastroenterology, rheumatology, and oncology in the United States and internationally. The company offers Acetadote, an injection for the treatment of acetaminophen ...

More about CPIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account